Searched for
US GDP THERAPY
GDP in TherapyThe US GDP is facing an identity crisis. It feels pressured by societal expectations. A taxpayer in Trumpland is battling the IRS. He tried...- India must choose its own path for a stronger and more equitable futureThe article critiques neoliberal free-market capitalism, highlighting its negative impacts on working-class people and advocating for a fai...
- India: The unsung hero of global health security in a world of rising costsIndia significantly contributes to global health security by providing essential generic and biosimilar medicines, which account for a larg...
- 'Running out of subjects to stay relevant': Internet roasts Andrew Tate for calling Bryan Johnson 'gay, fake'Controversial influencer Andrew Tate recently called Bryan Johnson, known for his anti-ageing endeavours, gay and fake, calling him out for...
- Dow outperforms in thin trading week, 1% shy of 40,000-point markWeighing on the tech-heavy Nasdaq, AI giant Nvidia shed 3.1%, leading losses among megacap growth peers. Traders see a 70% chance the Fed w...
- Why India needs to up the dose on R&D spend in pharmaceutical, medtech industryThe Indian pharma and medtech industry is on the cusp of big growth, and aims to grow to $500 billion by 2047. Thrust on R&D and innovation...
- India could face third highest economic burden of COPD from 2020-50: Lancet StudyThe global death toll of COPD was found to have increased by 14.1 per cent between 2009 and 2019, an increase that the study attributed to ...
- A pill in the works can bolster sagging global economic growthHarvard scientists claim to have found an anti-aging drug that rejuvenates the whole body. The find will go through further trials. It will...
- When net profits grow faster than economy: 6 stocks with up to 41% upside potentialStocks that consistently beat the economy when it comes to growth, have the ability to generate above-average returns in the medium to long...
- Stock market watch: What to expect from the week ending October 15, 2021“A convincing weekly close and bottom base moving up 17,400 to 17,630 are good signs and they hint that Nifty may go up to 18,300-400 in co...
- ICMR's 2nd sero-survey shows Indians far from achieving herd immunity against COVID-19: VardhanDuring an interaction with his social media followers, the minister said the Indian Council of Medical Research (ICMR) is actively research...
- Stocks are not rising for nothing! You can indeed invest for the long termIndia has consistently run current account deficits over the past several years.
- Fed boost fails to stem Wall Street routThe energy sector fell 5%, tracking a plunge in oil prices.
- World’s largest wealth manager tells investors: Lower expectationsHaefele joins his Wall Street counterparts in voicing concerns over returns this year.
- Young and vulnerable: Breast cancer on the rise among Indian women in late 20s, early 30sCancer burden has doubled in India over last 26 years.
- What I read this week: Long winter ahead for Indian market before springWith 85% of the currency in circulation removed, and the replacement likely to take longer, near-term disruption in economic growth could b...
- Number of cancer cases in India predicted to double in next 20 yearsIndia reports about one million new cases every year. This is 15% less than the US, whose population is one-third that of India.
- Patented drugs less affordable in India, but cheaper, says studyOver 78% of total expenditure on healthcare that Indians incur is out of pocket while in most other countries a share of this cost is eithe...
- Indian pharma industry to be in global top 5 by 2020: Ikon Marketing ConsultantAccording to a study, India will emerge as a leading global player in pharmaceutical industry by 2020, securing a place among the top five ...
- Wockhardt buys out Irish co for Rs 690 crMumbai-based pharmaceutical firm Wockhardt on Tuesday said the company has acquired Pinewood Laboratories, one of the largest and fastest g...
Load More
